Autonomix Medical
AMIX
8 hedge funds and large institutions have $144K invested in Autonomix Medical in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0.28% less ownership
Funds ownership: 0.57% → 0.3% (-0.28%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
70% less capital invested
Capital invested by funds: $477K → $144K (-$332K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.26K |
| 2 |
Mariner
Overland Park,
Kansas
|
+$111 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$95.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$64.6K |
| 3 |
BlackRock
New York
|
-$55 |
| 4 |
Morgan Stanley
New York
|
-$26 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Mariner
Overland Park,
Kansas
| $50.6K | +$111 | +2 | +0% |
|
|
IC
2
Ikarian Capital
Dallas,
Texas
| $35K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $27.9K | -$64.6K | -1,169 | -61% |
|
|
4
Citadel Advisors
Miami,
Florida
| $20.5K | -$95.2K | -1,722 | -76% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.8K | +$3.26K | +59 | +134% |
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3.22K | – | – | – |
|
|
7
BlackRock
New York
| $3.04K | -$55 | -1 | -1% |
|
|
IRC
8
Investors Research Corp
Atlanta,
Georgia
| $35 | – | – | – |
|
|
HI
9
Harbour Investments
Madison,
Wisconsin
| $18 | – | – | – |
|
|
SC
10
Swan Capital
Pensacola,
Florida
| $18 | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $17 | – | – | – |
|
12
Bank of America
Charlotte,
North Carolina
| $16 | – | – | – |
|
13
National Bank of Canada
Montreal,
Quebec, Canada
| $12 | – | – | – |
|
|
14
Morgan Stanley
New York
| – | -$26 | – | – |
|
AMIX Hedge Fund Activity: Q1 2025 in Review
8 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Autonomix Medical (AMIX) for Q1 2025, worth a combined $144K — down 70% from $477K a quarter earlier.
Fund positioning in AMIX was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $3.26K. The largest seller was Citadel Advisors, cutting an estimated $95.2K.
- 8 institutional investors held Autonomix Medical (AMIX) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $144K of Autonomix Medical stock for Q1 2025, down 70% quarter-over-quarter.
- 0 funds opened new Autonomix Medical positions in Q1 2025 and 0 closed out.
- The largest Autonomix Medical buyer in Q1 2025 was Tower Research Capital (TRC), an estimated $3.26K added.
- The largest Autonomix Medical seller in Q1 2025 was Citadel Advisors, an estimated $95.2K sold.
Based on aggregated 13F filings for Q1 2025.